Market Cap 501.56M
Revenue (ttm) 0.00
Net Income (ttm) -15.59M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 51,700
Avg Vol 65,034
Day's Range N/A - N/A
Shares Out 6.17M
Stochastic %K 30%
Beta 1.42
Analysts Strong Sell
Price Target $109.91

Company Profile

Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. The company develops ALXN1840, a late-stage, investigational once-daily and oral medicine; MNPR-101, a proprietary humanized monoclonal antibody that is conjugated with different radioisotopes for the treatment of advanced solid tumors expressing urokinase plasminogen activator receptor; and MNPR-101-Zr, a clinical-stage radiodiagnostic imagi...

Industry: Biotechnology
Sector: Healthcare
Phone: 847 388 0349
Address:
1000 Skokie Boulevard, Suite 350, Wilmette, United States
TA_Kongen
TA_Kongen Oct. 23 at 8:05 PM
$MNPR WTF. Last time I traded this was at like 5. What happened lmao.
1 · Reply
Dbi2
Dbi2 Oct. 21 at 7:09 PM
$MNPR what's going on?
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 20 at 3:51 PM
Lantheus loading up on $RADX $CATX $RANI $MNPR
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 19 at 12:53 AM
$RADX Another major investment into Radiopharm Theranostics by Lantheus being announced on Monday. $ATNM $CLRB $MNPR $CLRB
3 · Reply
MikeZ28
MikeZ28 Oct. 14 at 9:26 PM
$CABA 1000 shares deep in this one. Nice bounce back from last week. Hoping for a $NVAX or $MNPR type of run here over the next several weeks. Looking for a $15-20 price target.
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 14 at 5:10 PM
$56.4 million market cap is tiny in radiopharmaceutical’s… DEEP PIPELINE imaging & therapeutics $LNTH paying $250-300 mil per acquisition They just invested at $11.85 in Q1. Trading $4.75 below their last investment to bring ownership up to 12% PD-L1 and Her2 potential blockbusters $4-10 billion annually combined.. Rad101 high % success on Brain metastasis imaging batting 1000% in phase2a/b so far as I know- $400-800 mil annual imaging agent… $RADX $NNE $MNPR $MP
2 · Reply
Paraboljoker
Paraboljoker Oct. 14 at 8:02 AM
$XCH Next lithium to go like !$SPRB $DRUG $MNPR $AQMS
0 · Reply
Paraboljoker
Paraboljoker Oct. 14 at 12:03 AM
$XCH Undervalued🤌🏼💎 Has that returns of $SPRB $DRUG $MNPR $AQMS written all-over her💥 https://finance.yahoo.com/news/xcharge-north-america-ascentium-capital-113000948.html
0 · Reply
Paraboljoker
Paraboljoker Oct. 13 at 7:27 PM
$SUGP $SPRB $STI $MNPR $DRUG SUGP Matrix squeeze candidate☝🏼🌋
1 · Reply
Paraboljoker
Paraboljoker Oct. 13 at 7:11 PM
$SUGP 400K Float 🗞️ 1More PR and holymoly🇭🇰👀 Supply of shares will be shocked🔥 Could be new $SPRB $STI $MNPR $DRUG if u ask me
0 · Reply
Latest News on MNPR
Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025

May 7, 2025, 2:30 AM EDT - 6 months ago

Monopar Presents ALXN1840 Late-Breaker Data at EASL 2025


Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule

Aug 27, 2024, 4:05 PM EDT - 1 year ago

Monopar Regains Compliance with Nasdaq Minimum Bid Price Rule


Monopar Therapeutics Announces 1-for-5 Reverse Stock Split

Aug 9, 2024, 8:00 AM EDT - 1 year ago

Monopar Therapeutics Announces 1-for-5 Reverse Stock Split


Monopar and NorthStar Amend & Extend Collaboration

Jun 11, 2024, 7:30 AM EDT - 1 year ago

Monopar and NorthStar Amend & Extend Collaboration


Monopar Announces CFO Succession

May 24, 2024, 8:00 AM EDT - 1 year ago

Monopar Announces CFO Succession


TA_Kongen
TA_Kongen Oct. 23 at 8:05 PM
$MNPR WTF. Last time I traded this was at like 5. What happened lmao.
1 · Reply
Dbi2
Dbi2 Oct. 21 at 7:09 PM
$MNPR what's going on?
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 20 at 3:51 PM
Lantheus loading up on $RADX $CATX $RANI $MNPR
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 19 at 12:53 AM
$RADX Another major investment into Radiopharm Theranostics by Lantheus being announced on Monday. $ATNM $CLRB $MNPR $CLRB
3 · Reply
MikeZ28
MikeZ28 Oct. 14 at 9:26 PM
$CABA 1000 shares deep in this one. Nice bounce back from last week. Hoping for a $NVAX or $MNPR type of run here over the next several weeks. Looking for a $15-20 price target.
0 · Reply
RadioIsotope25
RadioIsotope25 Oct. 14 at 5:10 PM
$56.4 million market cap is tiny in radiopharmaceutical’s… DEEP PIPELINE imaging & therapeutics $LNTH paying $250-300 mil per acquisition They just invested at $11.85 in Q1. Trading $4.75 below their last investment to bring ownership up to 12% PD-L1 and Her2 potential blockbusters $4-10 billion annually combined.. Rad101 high % success on Brain metastasis imaging batting 1000% in phase2a/b so far as I know- $400-800 mil annual imaging agent… $RADX $NNE $MNPR $MP
2 · Reply
Paraboljoker
Paraboljoker Oct. 14 at 8:02 AM
$XCH Next lithium to go like !$SPRB $DRUG $MNPR $AQMS
0 · Reply
Paraboljoker
Paraboljoker Oct. 14 at 12:03 AM
$XCH Undervalued🤌🏼💎 Has that returns of $SPRB $DRUG $MNPR $AQMS written all-over her💥 https://finance.yahoo.com/news/xcharge-north-america-ascentium-capital-113000948.html
0 · Reply
Paraboljoker
Paraboljoker Oct. 13 at 7:27 PM
$SUGP $SPRB $STI $MNPR $DRUG SUGP Matrix squeeze candidate☝🏼🌋
1 · Reply
Paraboljoker
Paraboljoker Oct. 13 at 7:11 PM
$SUGP 400K Float 🗞️ 1More PR and holymoly🇭🇰👀 Supply of shares will be shocked🔥 Could be new $SPRB $STI $MNPR $DRUG if u ask me
0 · Reply
JarvisFlow
JarvisFlow Oct. 13 at 12:05 PM
Barclays has adjusted their stance on Monopar Therapeutics ( $MNPR ), setting the rating to Overweight with a target price of 125.
0 · Reply
notreload_ai
notreload_ai Oct. 13 at 10:06 AM
Barclays assigns Overweight rating to $MNPR with $125 price target, highlighting de-risked biotech opportunities in inflammation, rare disease, and oncology sectors. https://notreload.xyz/barclays-initiates-monopar-therapeutics-bullish-coverage/
0 · Reply
georgenobest
georgenobest Oct. 11 at 6:43 PM
$MNPR CATX more than 300% upside. Catalyst coming next week. The move just started https://in.investing.com/news/analyst-ratings/btig-initiates-coverage-on-perspective-therapeutics-stock-with-buy-rating-93CH-5038968
0 · Reply
DrevanTheStillblade
DrevanTheStillblade Oct. 7 at 11:14 AM
PRHI is suffocating the shorts. Borrow’s gone. Utilization near max. Short squeeze score nearly perfect. One green candle with volume and they scramble. $4.05 break = liftoff. $7$10 range is real.... . $AMST $ACHV $BLPH $VYNE $MNPR
0 · Reply
DARKP00L
DARKP00L Oct. 6 at 5:11 PM
$MNPR 12:59 on Oct. 06 2025 Raymond James Maintains Strong Buy on Monopar Therapeutics, Raises Price Target to $142 #tradeideas
0 · Reply
ya33
ya33 Oct. 6 at 5:09 PM
0 · Reply
JarvisFlow
JarvisFlow Oct. 6 at 4:59 PM
Raymond James has adjusted their stance on Monopar Therapeutics ( $MNPR ), setting the rating to Strong Buy with a target price of 80 → 142.
0 · Reply
FloatExplorer
FloatExplorer Oct. 5 at 12:14 PM
$MNPR Biotech with novel approach. High short interest. Potential squeeze setup if data positive. High risk/reward.
0 · Reply
Bullbear1010101
Bullbear1010101 Oct. 4 at 12:33 PM
$MNPR Seems top soon. bubble almost
0 · Reply
StockTwitsGhost
StockTwitsGhost Oct. 3 at 9:58 PM
$MNPR If MNPR csn do it, so can $CYCN 💪🏽
0 · Reply
TradeHuntFish
TradeHuntFish Oct. 3 at 1:06 PM
If GIPR becomes the next REIT-crypto hybrid play, the re rate will be violent. Add in a micro float, real tenants, and a book value that’s completely ignored this could be the next legendary rerate ticker. Eyes on this before it headlines. $MNPR $THMO $LGVN $HOOK $PEV
0 · Reply
outlawinvestor1
outlawinvestor1 Oct. 2 at 2:37 PM
$RADX $MNPR and $RADX are completely different companies with different value drivers. one is not an indicator of what the other can do. they're both good opportunities imho, but no need to compare.
3 · Reply